Sobi Articles
SOBI to distribute Exelixis' cancer drug Cometriq in EU
22 February 2013
SOBI links with Savient for co-promotion of Kineret in USA
19 February 2013
SOBI gains distribution rights for Megace, Monopril, Cefzil and Duricef from PharmaSwiss
13 February 2013
FDA approves SOBI's Kineret for the treatment of NOMID
8 January 2013
Positive Ph III results for Biogen Idec and SOBI's hemophilia B agent
27 September 2012
Showing 1-5 of 5 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
